Havranek, E P <br/><br/>
Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure.  [electronic resource] 

 -  Journal of the American College of Cardiology  Apr 1999 
 - 1174-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/s0735-1097(98)00695-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Angiotensin Receptor Antagonists<br/>Antihypertensive Agents--administration & dosage<br/>Biphenyl Compounds--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Heart Failure--blood<br/>Hemodynamics--drug effects<br/>Humans<br/>Irbesartan<br/>Male<br/>Middle Aged<br/>Norepinephrine--blood<br/>Receptor, Angiotensin, Type 1<br/>Receptor, Angiotensin, Type 2<br/>Safety<br/>Single-Blind Method<br/>Tetrazoles--administration & dosage<br/>Treatment Outcome